Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Tops Growth In Non-Prescription Drugs

This article was originally published in PharmAsia News

Executive Summary

At Beijing's recent International Pharmaceutical Federation World Self-Medication Industry Symposium, figures showed that as of Q2 2008, China's average growth rate of non-prescription drug revenue ranked first in the world over the past three years. According to the latest study jointly conducted by Nicholas Hall & Company and Jowin Communications, China's non-prescription drug sales hit $7.3 billion in 2007 and maintain an annual growth rate of roughly 11 percent, far higher than that of the world's average rate of 5.4 percent. Experts point out that non-prescription drugs have huge room for expansion, with market value of the sector expected to exceed $16.3 billion by 2017. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts